“We are committed to expediting the development of COVID-19 vaccines, but not at the expense of sound science and decision making. We will not jeopardize the public’s trust in our science-based, independent review of these or any vaccines. There’s too much at stake.” --Stephen M. Hahn, M.D., FDA Commissioner, and Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
FDA has rigorous scientific and regulatory processes in place to facilitate development and ensure the safety, effectiveness, and quality of COVID-19 vaccines. Learn more and bookmark our new web page at: www.fda.gov/covid19vaccines. (October 6, 2020)
|
|
|